This study is testing whether the drug cabozantinib can help control advanced germ cell tumors that have stopped responding to standard chemotherapy. It will involve about 50 adults whose cancer has progressed despite previous treatments. Participants will take the oral medicatio…
Phase: PHASE2 • Sponsor: Jennifer King • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC